Academic Bibliography

 Search 200 years of publications by Ghent University researchers.
Advanced search
1 file | 2.28 MB
Add to list
  1. Search results
  2. ZEB2 drives immature T-cell lymphobla...

ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling

Steven Goossens (UGent) , Enrico Radaelli, Odile Blanchet, Kaat Durinck (UGent) , Joni Van der Meulen (UGent) , Sofie Peirs (UGent) , Tom Taghon (UGent) , Cedric S Tremblay, Magdaline Costa, Morvarid Farhang Ghahremani, et al.
(2015) NATURE COMMUNICATIONS. 6.
Author
Organization
Abstract
Early T-cell precursor leukaemia (ETP-ALL) is a high-risk subtype of human leukaemia that is poorly understood at the molecular level. Here we report translocations targeting the zinc finger E-box-binding transcription factor ZEB2 as a recurrent genetic lesion in immature/ETP-ALL. Using a conditional gain-of-function mouse model, we demonstrate that sustained Zeb2 expression initiates T-cell leukaemia. Moreover, Zeb2-driven mouse leukaemia exhibit some features of the human immature/ETP-ALL gene expression signature, as well as an enhanced leukaemia-initiation potential and activated Janus kinase (JAK)/signal transducers and activators of transcription (STAT) signalling through transcriptional activation of IL7R. This study reveals ZEB2 as an oncogene in the biology of immature/ETP-ALL and paves the way towards pre-clinical studies of novel compounds for the treatment of this aggressive subtype of human T-ALL using our Zeb2-driven mouse model.
Keywords
GENES, SIP1, EXPRESSION, CANCER, MIR-200 FAMILY, OF-FUNCTION MUTATIONS, MICE, PRECURSOR, NOTCH1, GAIN

Downloads

  • Download
    ncomms6794.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 2.28 MB

Citation

Please use this url to cite or link to this publication:

MLA
Goossens, Steven, et al. “ZEB2 Drives Immature T-Cell Lymphoblastic Leukaemia Development via Enhanced Tumour-Initiating Potential and IL-7 Receptor Signalling.” NATURE COMMUNICATIONS, vol. 6, 2015, doi:10.1038/ncomms6794.
APA
Goossens, S., Radaelli, E., Blanchet, O., Durinck, K., Van der Meulen, J., Peirs, S., … Haigh, J. (2015). ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling. NATURE COMMUNICATIONS, 6. https://doi.org/10.1038/ncomms6794
Chicago author-date
Goossens, Steven, Enrico Radaelli, Odile Blanchet, Kaat Durinck, Joni Van der Meulen, Sofie Peirs, Tom Taghon, et al. 2015. “ZEB2 Drives Immature T-Cell Lymphoblastic Leukaemia Development via Enhanced Tumour-Initiating Potential and IL-7 Receptor Signalling.” NATURE COMMUNICATIONS 6. https://doi.org/10.1038/ncomms6794.
Chicago author-date (all authors)
Goossens, Steven, Enrico Radaelli, Odile Blanchet, Kaat Durinck, Joni Van der Meulen, Sofie Peirs, Tom Taghon, Cedric S Tremblay, Magdaline Costa, Morvarid Farhang Ghahremani, Jelle De Medts, Sona Bartunkova, Katharina Haigh, Claire Schwab, Natalie Farla, Tim Pieters, Filip Matthijssens, Nadine Van Roy, J Adam Best, Kim Deswarte, Pieter Bogaert, Catherine Carmichael, Adam Rickard, Santi Suryani, Lauryn S Bracken, Raed Alserihi, Kirsten Cante-Barret, Lieven Haenebalcke, Emmanuelle Clappier, Pieter Rondou, Karolina Slowicka, Danny Huylebroeck, Ananda W Goldrath, Viktor Janzen, Matthew P McCormack, Richard B Lock, David J Curtis, Christine Harrison, Geert Berx, Franki Speleman, Jules PP Meijerink, Jean Soulier, Pieter Van Vlierberghe, and Jody Haigh. 2015. “ZEB2 Drives Immature T-Cell Lymphoblastic Leukaemia Development via Enhanced Tumour-Initiating Potential and IL-7 Receptor Signalling.” NATURE COMMUNICATIONS 6. doi:10.1038/ncomms6794.
Vancouver
1.
Goossens S, Radaelli E, Blanchet O, Durinck K, Van der Meulen J, Peirs S, et al. ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling. NATURE COMMUNICATIONS. 2015;6.
IEEE
[1]
S. Goossens et al., “ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling,” NATURE COMMUNICATIONS, vol. 6, 2015.
@article{5889715,
  abstract     = {{Early T-cell precursor leukaemia (ETP-ALL) is a high-risk subtype of human leukaemia that is poorly understood at the molecular level. Here we report translocations targeting the zinc finger E-box-binding transcription factor ZEB2 as a recurrent genetic lesion in immature/ETP-ALL. Using a conditional gain-of-function mouse model, we demonstrate that sustained Zeb2 expression initiates T-cell leukaemia. Moreover, Zeb2-driven mouse leukaemia exhibit some features of the human immature/ETP-ALL gene expression signature, as well as an enhanced leukaemia-initiation potential and activated Janus kinase (JAK)/signal transducers and activators of transcription (STAT) signalling through transcriptional activation of IL7R. This study reveals ZEB2 as an oncogene in the biology of immature/ETP-ALL and paves the way towards pre-clinical studies of novel compounds for the treatment of this aggressive subtype of human T-ALL using our Zeb2-driven mouse model.}},
  articleno    = {{5794}},
  author       = {{Goossens, Steven and Radaelli, Enrico and Blanchet, Odile and Durinck, Kaat and Van der Meulen, Joni and Peirs, Sofie and Taghon, Tom and Tremblay, Cedric S and Costa, Magdaline and Ghahremani, Morvarid Farhang and De Medts, Jelle and Bartunkova, Sona and Haigh, Katharina and Schwab, Claire and Farla, Natalie and Pieters, Tim and Matthijssens, Filip and Van Roy, Nadine and Best, J Adam and Deswarte, Kim and Bogaert, Pieter and Carmichael, Catherine and Rickard, Adam and Suryani, Santi and Bracken, Lauryn S and Alserihi, Raed and Cante-Barret, Kirsten and Haenebalcke, Lieven and Clappier, Emmanuelle and Rondou, Pieter and Slowicka, Karolina and Huylebroeck, Danny and Goldrath, Ananda W and Janzen, Viktor and McCormack, Matthew P and Lock, Richard B and Curtis, David J and Harrison, Christine and Berx, Geert and Speleman, Franki and Meijerink, Jules PP and Soulier, Jean and Van Vlierberghe, Pieter and Haigh, Jody}},
  issn         = {{2041-1723}},
  journal      = {{NATURE COMMUNICATIONS}},
  keywords     = {{GENES,SIP1,EXPRESSION,CANCER,MIR-200 FAMILY,OF-FUNCTION MUTATIONS,MICE,PRECURSOR,NOTCH1,GAIN}},
  language     = {{eng}},
  pages        = {{12}},
  title        = {{ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling}},
  url          = {{http://doi.org/10.1038/ncomms6794}},
  volume       = {{6}},
  year         = {{2015}},
}
Altmetric
View in Altmetric
Web of Science
Times cited: